BIOMAT Database Logo BIOMAT Database Logo

Design of vectors for efficient expression of human purine nucleoside phosphorylase in skin fibroblasts from enzyme-deficient humans. 1988

W R Osborne, and A D Miller
Department of Pediatrics, University of Washington, Seattle 98195.

Purine nucleoside phosphorylase (PNP; purine-nucleoside orthophosphate ribosyltransferase, EC 2.4.2.1) deficiency is an inherited disorder associated with a severe immune defect that is fatal. Enzyme replacement therapy is an attractive approach to treatment of this disease. To this aim we constructed retroviral vectors containing a human PNP cDNA and a selectable gene encoding neomycin phosphotransferase. PNP expression was controlled by either the early promoter from simian virus 40, the immediate early promoter from human cytomegalovirus, or the retroviral promoter. Cultured skin fibroblasts from two unrelated PNP-deficient patients that were infected with these vectors expressed mean PNP activities of 0.03, 0.74, and 5.9 mumol/hr per mg of protein, respectively. The latter infectants had PNP activities eight times the level of 0.74 mumol/hr per mg of protein observed in normal skin fibroblasts, enabling rapid metabolism of exogenous deoxyguanosine, the cytotoxic metabolite that accumulates in the plasma of PNP-deficient patients. These experiments indicate that viral long terminal repeat was the strongest promoter for expression of PNP and suggest the potential of human skin fibroblasts as vehicles for therapeutic gene expression.

UI MeSH Term Description Entries
D010430 Pentosyltransferases Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003849 Deoxyguanosine A nucleoside consisting of the base guanine and the sugar deoxyribose.
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006151 Guanosine A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

W R Osborne, and A D Miller
Inosine uptake by cultured fibroblasts from normal and purine nucleoside phosphorylase-deficient humans.
June 1977, The Journal of biological chemistry,
W R Osborne, and A D Miller
Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
August 1978, Proceedings of the National Academy of Sciences of the United States of America,
W R Osborne, and A D Miller
Catalytic-site design for inverse heavy-enzyme isotope effects in human purine nucleoside phosphorylase.
June 2017, Proceedings of the National Academy of Sciences of the United States of America,
W R Osborne, and A D Miller
Purine nucleoside phosphorylase from human erythrocytes.
January 1978, Methods in enzymology,
W R Osborne, and A D Miller
Design of purine nucleoside phosphorylase inhibitors.
November 1986, Federation proceedings,
W R Osborne, and A D Miller
Purine metabolism in intact cells from a purine nucleoside phosphorylase deficient child.
January 1984, Advances in experimental medicine and biology,
W R Osborne, and A D Miller
Expression of human malaria parasite purine nucleoside phosphorylase in host enzyme-deficient erythrocyte culture. Enzyme characterization and identification of novel inhibitors.
September 1986, The Journal of biological chemistry,
W R Osborne, and A D Miller
Characterization of the subunits of purine nucleoside phosphorylase from cultured normal human fibroblasts.
August 1979, Biochemical genetics,
W R Osborne, and A D Miller
Purine nucleoside phosphorylase from human erythrocytes: physiocochemical properties of the crystalline enzyme.
January 1978, Biochemistry,
W R Osborne, and A D Miller
Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice.
August 2012, Neurobiology of disease,
Copied contents to your clipboard!